110
Views
7
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

The value of biochemical markers for risk stratification prior to hospital admission in acute chest pain

&
Pages 197-204 | Received 18 Oct 2007, Published online: 10 Jul 2009

References

  • Fibrinolytic Therapy Trialists’ (FTT) Collaborative group: Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311–22.
  • Chambless L, Keil U, Dobson A, Mähönen M, Kuulasma K, Rajakangas A-M, et al. for the WHO MONICA project. Population versus clinical view of case fatality from acute coronary heart disease. Results from the WHO MONICA project 1985–1990. Circulation 1997; 96: 3849–59
  • Abildstrom SZ, Rasmussen S, Madsen M. Changes in hospitalization rate and mortality after acute myocardial infarction in Denmark after diagnostic criteria and methods changed. Eur Heart J. 2005; 26: 990–95
  • Kavsak PA, MacRae AR, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, et al. The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction. Am Heart J. 2006; 152: 118–25
  • Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation 2007; 116: 2634–53
  • Svensson L, Isaksson L, Axelsson C, Nordlander R, Herlitz J. Predictors of myocardial damage prior to hospital admission among patients with acute chest pain or other symptoms raising suspicion of acute coronary syndrome. Cor Art Dis. 2003; 14: 225–31
  • Weaver WB, Eisenberg MS, Martin JS, Litwin PE, Shaeffer SM, Ho MT, et al. Myocardial infarction triage and intervention project—phase I: Patient characteristics and feasibility of pre-hospital initiation of thrombolytic therapy. J Am Coll Cardiol. 1990; 15: 925–31
  • Herlitz J, Karlson BW, Bång A, Lindqvist J. Characteristics and outcome for patients with acute chest pain in relation to whether or not they were transported by ambulance. Eur J Emerg Med. 2000; 7: 195–200
  • Grijseels EW, Deckers JW, Hoes AW, et al. Pre-hospital triage of patients with suspected myocardial infarction. Evaluation of previously developed algorithms and new proposals. Eur Heart J. 1995; 16: 325–32
  • Gust R, Gust A, Böttiger BW, Böhrer H, Martin E. Bedside troponin T testing is not useful for early out-of-hospital diagnosis of myocardial infarction. Acta Anaesthesiol Scand. 1998; 42: 414–7
  • Schuchert A, Hamm C, Scholz J, Klimmeck S, Goldmann B, Meinertz T. Prehospital testing for troponin T in patients with suspected acute myocardial infarction. Am Heart J. 1999; 138: 45–8
  • Roth A, Malov N, Golovner M, Sander J, Shapira I, Kaplinsky E, et al. The “SHAHAL” experience in Israel for improving diagnosis of acute coronary syndromes in the prehospital setting. Am J Cardiol. 2001; 88: 608–10
  • Svensson L, Axelsson C, Nordlander R, Herlitz J. Elevation of biochemical markers for myocardial damage prior to hospital admission in patients with acute chest pain or other symptoms raising suspicion of acute coronary syndrome. J Intern Med. 2003; 253: 311–9
  • Di Serio F, Lovero R, Leone M, De Sario R, Ruggieri V, Varraso L, et al. Integration between the tele-cardiology unit and the central laboratory: methodological and clinical evaluation of point-of-care testing cardiac marker in the ambulance. Clin Chem Lab Med. 2006; 44: 768–73
  • Ecollan P, Collet J-P, Boon G, Tanguy M-L, Fievet M-L, Haas R, et al. Pre-hospital detection of acute myocardial infarction with ultra-rapid human fatty acid-binding protein (H-FABP) immunoassay. Inter J Cardiol. 2007; 119: 349–54
  • O'Donoghue M, de Lemos JA, Morrow DA, Murphy SA, Buros JL, Cannon CP, et al. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes. Circulation 2006; 114: 550–7
  • Mad P, Domanovits H, Fazelnia C, Stiassny K, Russmüller G, Cseh A, et al. Human heart-type fatty-acid-binding protein as a point-of-care test in the early diagnosis of acute myocardial infarction. Q J Med. 2007; 100: 203–10
  • Agewall S, Olsson T, Löwbeer C. Usefulness of troponin levels below the diagnostic cut-off level for acute myocardial infarction in predicting prognosis in unselected patients admitted to the coronary care unit. Am J Cardiol. 2007; 99: 1357–9
  • Svensson L, Axelsson C, Nordlander R, Herlitz J. Prognostic value of biochemical markers, twelve lead ECG and patients characteristics among patients calling for an ambulance due to a suspected acute coronary syndrome. JIM 2004; 255: 469–77
  • Ohman EM, Armstrong PW, White HD, et al. Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTO III Investigators. Global use of strategies to open occluded coronary arteries. Am J Cardiol. 1999; 84: 1281–6
  • Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, et al. National Academy of Clinical Biochemistry Laboratory Medicine. Practice guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 2007; 115: e356–e75
  • Svensson L, Axelsson C, Nordlander R, Herlitz J. Prehospital identification of acute coronary syndrome/myocardial infarction in relation to ST-elevation. Inter J Cardiol. 2005; 98: 237–44
  • Johansson I, Strömberg A, Swahn E. Factors related to delay times in patients with suspected acute myocardial infarction. Heart Lung 2004; 33: 291–300
  • Qin Q-P, Wittfooth S, Pettersson K. Measurement and clinical significance of circulating PAPP-A in ACS patients. Clin Chim Acta 2007; 380: 59–67
  • Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P. Macrophage myeloperoxidase regulation by macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol. 2001; 158: 879–91
  • Brennan M-L, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, et al. Prognostic value of myeloperoxidase in patients with chest pain. New Engl J Med. 2003; 349: 1595–604
  • Hayashida K, Kume N, Murase T, Minami M, Nakagawa D, Inada T, et al. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome. A novel marker for early diagnosis. Circulation 2005; 112: 812–8
  • Danne O, Möckel M, Lueders C, Mügge C, Zschunke GA, Lufft H, et al. Prognostic implications of elevated whole blood choline levels in acute coronary syndromes. Am J Cardiol. 2003; 91: 1060–7
  • Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998; 394: 200–3
  • Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, et al. Soluble CD40 Ligand in acute coronary syndromes. New Engl J Med. 2003; 348: 1104–11
  • Collinson PO, Gaze DC, Bainbridge K, Morris F, Morris B, Price A, et al. Utility of admission cardiac troponin and “Ischaemia modified albumin” measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department. Emerg Med J. 2006; 23: 256–61
  • Peacock F, Morris DL, Anwaruddin S, Christenson RH, Collinson PO, Goodacre SW, et al. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J. 2006; 152: 253–62
  • Omland T, Persson A, Ng L, O'Brien R, Karlsson T, Herlitz J, et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002; 106: 2913–8
  • Christ M, Laule K, Klima T, Hochholzer W, Breidthardt T, Perruchoud AP, et al. Multimarker strategy for risk prediction in patients presenting with acute dyspnea to the emergency department. Inter J Cardiol. 2008; 126: 73–8
  • James SK, Lindbäck J, Tilly J, Siegbahn A, Venge P, Armstrong P, et al. Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes. JACC 2006; 48: 1146–54
  • Brunetti ND, Troccoli R, Correale M, Pellegrino PL, Di Biase M. C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings. Inter J Cardiol. 2006; 109: 248–56
  • Hartford M, Wiklund O, Mattsson-Hultén L, Perers E, Person A, Herlitz J, et al. CRP, interleukin-6, secretory phospholipase A2 group IIA, and intercellular adhesion molecule-1 during the early phase of acute coronary syndromes and long-term follow-up. Int J Cardiol. 2006; 108: 55–62
  • Sanchis J, Bodí V, Núñez J, Bertomeu V, Consuegra L, José M, et al. Prognostic usefulness of white blood cell count on admission and one-year outcome in patients with non-ST-segment elevation acute chest pain. Am J Cardiol. 2006; 98: 885–9
  • Steg PG, Cambou JP, Goldstein P, et al. Bypassing the emergency room reduces delays and mortality in ST-elevation myocardial infarction: the USIC 2000 registry. Heart 2006; 92: 1378–83
  • Bång A, Grip L, Herlitz J, Kihlgren S, Karlsson T, Caidahl K, et al Lower mortality after prehospital recognition and treatment followed by fast tracking to coronary care compared with admittance via emergency department in patients with ST-elevation myocardial infarction. Int J Cardiol. 2007 Nov 9. (Epub ahead of print.)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.